2 drug(s) with this reaction
33 total reports
Product Odour Abnormal has been reported as an adverse reaction across 2 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 33 adverse event reports mention product odour abnormal in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with product odour abnormal, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have product odour abnormal listed in their FDA adverse event reports, sorted by report count:
In addition to product odour abnormal, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
2 drug(s) manufactured by Chattem Inc have product odour abnormal listed in their FDA adverse event reports: SELENIUM SULFIDE, TROLAMINE SALICYLATE.
There are a combined 33 reports of product odour abnormal across 2 Chattem Inc drug(s) in the FDA adverse event database.